srunni

12 ms·

61.
Biogen R&D Chief Launches Exosome Biology Startup to Fight Cancer, Alzheimers(forbes.com)
1 points by srunni 11y ago|0 comments
62.
by srunni 11y ago
A great book was published on this topic 2 months ago, called Risky Medicine : http://www.amazon.com/Risky-Medicine-Quest-Cure-Uncertainty-... Podcast interview of the author, released yesterday: http://www.econ
63.
The Gene Hackers(newyorker.com)
39 points by srunni 11y ago|1 comments
64.
by srunni 11y ago
Also see: https://en.wikipedia.org/wiki/The_Unreasonable_Effectiveness... (full article: https://www.dartmouth.edu/~matc/MathDrama/reading/Wigner.htm... )
65.
Software Eats Healthcare, for Dummies(alexdanco.com)
1 points by srunni 11y ago|0 comments
66.
by srunni 11y ago
They probably started in NY because most of the founding team is living in/near NYC, according to a document filed with the NY DFS ( http://www.dfs.ny.gov/insurance/exam_rpt/x9475o13.pdf ). It also states that
67.
by srunni 11y ago
What Oscar Is Up Against ( http://go.theinformation.com/152dc2 ) > After two years in operation, the financial trajectory is becoming clear, both in terms of the growth and the costs. In New York, the company projected a
68.
by srunni 11y ago
The board may not have any real voting power, "thanks to a supervoting share structure that gives insiders 100 votes per share." Holmes unilaterally decides who's on the board. https://www.theinformation.com/i
69.
by srunni 11y ago
> What the tech companies moving into LS are paying is way out of line with what the "native" LS companies are paying, too. This is an interesting observation, particularly when considering the engineering vs. science distincti
70.
by srunni 11y ago
I'm not saying that I'm surprised that he spoke out - I mean the timing of it is unusual. Why didn't he say something when Holmes was appointed to the Board of Fellows, or when the company first started its PR blitz in late 2
71.
by srunni 11y ago
This Theranos story just keeps getting more and more bizarre. George Church publicly criticized its board in a remark to the WaPo ( http://www.washingtonpost.com/news/wonkblog/wp/2015/10/15/th...
72.
by srunni 11y ago
It seems that this isn't an issue for Theranos's FDA-approved HSV-1 assay. See Table 16 and Figure 1: http://www.accessdata.fda.gov/cdrh_docs/reviews/K143236.pdf However, the skill level of whoever perfo
73.
Theranos Isn’t the Only One Chasing Needle-Free Blood Tests(wired.com)
2 points by srunni 11y ago|0 comments
74.
by srunni 11y ago
> I like the thrust of your argument, but from my perspective in Singapore/Asia, that's not quite what I see...The US-educated scions of well-connected families are especially responsible for techologising their behemoth family
75.
by srunni 11y ago
I'm interested in your opinion on the potential for the disruption of the academic publishing system, and what role YCR can play in that. For example, making it easy for 3rd parties to reanalyze data generated/published by another
76.
by srunni 11y ago
E-Commerce is a Bear , by Andy Dunn (CEO of Bonobos) is fantastic: https://medium.com/@dunn/e-commerce-is-a-bear-d233f02d52a5
77.
by srunni 11y ago
> The current of the flowing river does not cease, and yet the water is not the same water as before. The foam that floats on stagnant pools, now vanishing, now forming, never stays the same for long. So, too, it is with the people and d
78.
by srunni 11y ago
> Were I to say that the expression of gene A is 'random,' then it would seem to imply that there is some minute chance that the result is a billion copies of the gene Not at all (in mathematical terms, anyway). You can certain
79.
Peter Thiel: A Biotech Education, in Progress(blogs.sciencemag.org)
2 points by srunni 11y ago|0 comments
80.
by srunni 11y ago
> The distinction between being 'stocastic' and 'random' is one of 'unpredictable & determined' vs ' unpredictable & undetermined' Also from that page you linked: > a purely stochastic s
81.
by srunni 11y ago
> Biotech startups are almost exclusively (to my knowledge, exclusively) long shots with potential large upswings. And it's these sorts of long shots that he wants to avoid. He thinks that Stemcentrx has more certainty in its outcom
82.
by srunni 11y ago
> The distinction between being 'stocastic' and 'random' is one of 'predictability & determined' vs 'undetermined'. The first sentence on the page you linked to suggests otherwise: > The ter
83.
by srunni 11y ago
> You're never sure if it's going to work in the laboratory! Research is mostly "try something new, then try another new thing when that fails." It's "wasteful" because it's guided trial and error,
84.
by srunni 11y ago
I don't mean the fabrication of those components, I mean their operation. In living organisms, eliminating randomness in their operation would change their intended behavior in several ways - randomness is a feature, not a bug, in livi
85.
by srunni 11y ago
> technology is trying to overcome the randomness that is nature This is a major reason why consumer electronics and information technology have enabled so many more rapidly scalable businesses in recent decades than other industries (he
86.
Peter Thiel Backs Biotech Unicorn Fighting Cancer Stem Cells(technologyreview.com)
3 points by srunni 11y ago|0 comments
87.
by srunni 11y ago
> Although the polypill could produce substantial public health benefits, people in the United States are unlikely to find out anytime soon. This is because the pill’s price is so low (≤$1 per tablet) and the cost of the large clinical t
88.
by srunni 11y ago
The full text can be found here: http://www.rle.mit.edu/sbg/wp-content/uploads/2014/09/Sequen...
89.
Google's Calico widens its R&D net with QB3 partnership(fiercebiotech.com)
1 points by srunni 12y ago|0 comments
90.
by srunni 12y ago
There are already many well-established biotech accelerators/incubators in Boston (Lab Central, PureTech Ventures, Third Rock Ventures, Flagship Ventures, Atlas Venture, etc.), Seattle (Accelerator Corporation; also in NYC), NYC (Harle

More ›